Cargando…
Outcomes of Pediatric Osteogenesis Imperfecta Patients Requiring Port‐a‐Cath Placement for Long‐Term Vascular Access
Intravenous (iv) bisphosphonates are widely used to treat the skeletal manifestations of osteogenesis imperfecta (OI). Obtaining peripheral iv access in pediatric patients with OI is often difficult and traumatic. Although this may be mitigated with surgically placed iv ports (port‐a‐caths), surgeon...
Autores principales: | White, Andrew C, Byrd, Jay J, Schissel, Makayla, Strudthoff, Elizabeth, Wallace, Maegen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339085/ https://www.ncbi.nlm.nih.gov/pubmed/37457882 http://dx.doi.org/10.1002/jbm4.10752 |
Ejemplares similares
-
Obstructive Constipation in Two Patients With Severe Osteogenesis Imperfecta and Acetabular Protrusio
por: Stockwell, Erin, et al.
Publicado: (2022) -
Targeting TGF-β for treatment of osteogenesis imperfecta
por: Song, I-Wen, et al.
Publicado: (2022) -
A Port‐A‐Cath in aorta
por: Zoltowska, Dominika, et al.
Publicado: (2018) -
Port-a-Cath Insertion in Pediatric Patients With Malignancy in Tabuk
por: Ghmaird, Asmaa S, et al.
Publicado: (2021) -
“Osteogenesis Imperfecta Patients Wish Orthopedic Surgeons Had Better Strategies to Help with…”—Results of a Patient and Parent-Oriented Survey
por: Flanagan, Jill, et al.
Publicado: (2023)